Predictors of Conversion to Neurodegenerative Disease in REM Sleep Behavior Disorder
Several prodromal symptoms in REM sleep behavior disorder are highly associated with conversion to neurodegenerative diseases.
All articles by Alicia Ciccone
Efficacy of Disease-Modifying Drugs for Multiple Sclerosis May Decrease With Age
A regression model showed that efficacy of DMTs significantly decreased until age 53, after which disease progression is not affected by DMTs.
Wearable Sensors May Help Predict On, Off States in Parkinson Disease
Wearable technology may help monitor on/off states in patients with Parkinson disease in an outpatient setting.
Predicting Stroke Subtype Risk With Retinal Microvascular Abnormalities
The results suggest a noninvasive method for predicting individualized risk for certain stroke subtypes.
Solriamfetol Associated With Improvement in Narcolepsy Types 1 and 2
Patients in the 2 highest dosing groups saw significant, sustained improvements over the 12-week study.
Multiple Sclerosis Guidelines: AAN’s Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
The new guidelines focus on helping clinicians decide when to initiate, switch, or discontinue disease-modifying therapies for multiple sclerosis.
Novel Therapy May Improve Symptoms in Early Huntington Disease
Researchers found that high doses of the novel antisense oligonucleotide were associated with lower concentrations of mutant huntingtin protein in the cerebrospinal fluid and brain.
American Academy of Neurology Annual Meeting 2018: What to Expect
Neurology Advisor will provide live coverage of the 2018 American Academy of Neurology Annual Meeting from Los Angeles, CA.
Siponimod Reduces Disability Progression in Secondary Progressive Multiple Sclerosis
Further research should focus on establishing whether siponimod exerts its effect on the pathogenic processes associated with disease progression or activity, or both.
FDA Approves Expanded Treatment Window for Clot Retrieval Device in Acute Ischemic Stroke
The FDA has expanded the treatment window for a clot retrieval device in certain patients presenting with acute ischemic stroke.
Next post in Stroke
